These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31306048)

  • 1. Synthesis and
    Chatale BC; Degani MS
    Drug Dev Ind Pharm; 2019 Oct; 45(10):1590-1598. PubMed ID: 31306048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclodextrin-based oral dissolving films formulation of taste-masked meloxicam.
    Samprasit W; Akkaramongkolporn P; Kaomongkolgit R; Opanasopit P
    Pharm Dev Technol; 2018 Jun; 23(5):530-539. PubMed ID: 29103353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fast releasing oral electrospun PVP/CD nanofiber mats of taste-masked meloxicam.
    Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Kaomongkolgit R; Opanasopit P
    Int J Pharm; 2015 Jun; 487(1-2):213-22. PubMed ID: 25899284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of solubility enhancement on nasal absorption of meloxicam.
    Horváth T; Ambrus R; Völgyi G; Budai-Szűcs M; Márki Á; Sipos P; Bartos C; Seres AB; Sztojkov-Ivanov A; Takács-Novák K; Csányi E; Gáspár R; Szabó-Révész P
    Eur J Pharm Sci; 2016 Dec; 95():96-102. PubMed ID: 27260088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.
    Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Opanasopit P
    Drug Dev Ind Pharm; 2015 Jun; 41(6):1006-16. PubMed ID: 24865111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of meloxicam and lornoxicam transdermal patches: Preparation, physical characterization, ex vivo and in vivo studies.
    Yener G; Üner M; Gönüllü Ü; Yildirim S; Kiliç P; Aslan SS; Barla A
    Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1466-73. PubMed ID: 21048338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injectable polyamide-amine dendrimer-crosslinked meloxicam-containing poly-γ-glutamic acid hydrogel for prevention of postoperative tissue adhesion through inhibiting inflammatory responses and balancing the fibrinolytic system.
    Li X; Cai J; Duan X; Zhang Y; Cui M; Wang S; An X; Wang H
    J Colloid Interface Sci; 2024 Sep; 670():486-498. PubMed ID: 38772264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for meloxicam delivery to and across the skin: a review.
    Chen J; Gao Y
    Drug Deliv; 2016 Oct; 23(8):3146-3156. PubMed ID: 26956920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical assessment of the potential of a 3D chitosan drug delivery system with sodium meloxicam for treating complications following tooth extraction.
    Nowak KM; Bodek KH; Szterk A; Rudnicka K; Szymborski T; Kosieradzki M; Fiedor P
    Int J Biol Macromol; 2019 Jul; 133():1019-1028. PubMed ID: 30986462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sterility and Stability of Diluted Meloxicam in Compounded Multi-dose Vial after 365 Days.
    Kawano HK; Simonek GD; Moffitt AD; Tahara JM; Brignolo AL
    J Am Assoc Lab Anim Sci; 2019 Sep; 58(5):594-596. PubMed ID: 31383049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bovine serum albumin-meloxicam nanoaggregates laden contact lenses for ophthalmic drug delivery in treatment of postcataract endophthalmitis.
    Zhang W; Zu D; Chen J; Peng J; Liu Y; Zhang H; Li S; Pan W
    Int J Pharm; 2014 Nov; 475(1-2):25-34. PubMed ID: 25158220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self nanoemulsifying granules (SNEGs) of meloxicam: preparation, characterization, molecular modeling and evaluation of in vivo anti-inflammatory activity.
    Parekh VJ; Desai ND; Shaikh MS; Shinde UA
    Drug Dev Ind Pharm; 2017 Apr; 43(4):600-610. PubMed ID: 28005437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biowaiver studies of newly optimized meloxicam tablets.
    Zafar F; Khan S; Ali H; Shah SN; Bushra R; Naqvi GR; Maroof K; Khan MA; Nisa Z
    Pak J Pharm Sci; 2018 Jul; 31(4(Supplementary)):1469-1474. PubMed ID: 30058537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eutexia for enhanced dissolution rate and anti-inflammatory activity of nonsteroidal anti-inflammatory agents: Caffeine as a melting point modulator.
    Alshaikh RA; Essa EA; El Maghraby GM
    Int J Pharm; 2019 May; 563():395-405. PubMed ID: 30978486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prodrug approach involving in situ depot formation to achieve localized and sustained action of diclofenac after joint injection.
    Thing M; Ågårdh L; Larsen S; Rasmussen R; Pallesen J; Mertz N; Kristensen J; Hansen M; Østergaard J; Larsen CS
    J Pharm Sci; 2014 Dec; 103(12):4021-4029. PubMed ID: 25354787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance.
    Engelhardt G; Homma D; Schlegel K; Utzmann R; Schnitzler C
    Inflamm Res; 1995 Oct; 44(10):423-33. PubMed ID: 8564518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of meloxicam and dexketoprofen on postoperative adhesion formation in a rat uterine horn surgical model.
    Keskin HL; Akkus SM; Sirin YS; Ustuner I; Keles H; Ide T; Avsar AF
    J Minim Invasive Gynecol; 2013; 20(2):185-91. PubMed ID: 23298631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of a nonsteroidal anti-inflammatory polymeric prodrug for sustained and site-specific delivery.
    Chandrasekar MJ; Ravichandran M; Nanjan MJ; Suresh B
    Drug Dev Ind Pharm; 2001 Oct; 27(9):959-64. PubMed ID: 11763474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of meloxicam/ethanolamine salt formation on percutaneous absorption of meloxicam.
    Ki HM; Choi HK
    Arch Pharm Res; 2007 Feb; 30(2):215-21. PubMed ID: 17366744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and comparison of spray dried non-porous and large porous particles containing meloxicam for pulmonary drug delivery.
    Chvatal A; Ambrus R; Party P; Katona G; Jójárt-Laczkovich O; Szabó-Révész P; Fattal E; Tsapis N
    Int J Pharm; 2019 Mar; 559():68-75. PubMed ID: 30677482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.